請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37791
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蘇銘嘉(Ming-Jai Su) | |
dc.contributor.author | Hui-Chun Ku | en |
dc.contributor.author | 辜惠君 | zh_TW |
dc.date.accessioned | 2021-06-13T15:44:00Z | - |
dc.date.available | 2008-08-13 | |
dc.date.copyright | 2008-08-13 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-03 | |
dc.identifier.citation | Akashi-Takamura, S. and K. Miyake, 2006, Toll-like receptors (TLRs) and immune disorders, J Infect Chemother 12, 233.
Bartling, B., J. Holtz and D. Darmer, 1998, Contribution of myocyte apoptosis to myocardial infarction?, Basic Res Cardiol 93, 71. Bazett, H.C., 1920, An analysis of the time relations of electrogram., heart 7, 353. Beckman, J.S. and J.P. Crow, 1993, Pathological implications of nitric oxide, superoxide and peroxynitrite formation, Biochem Soc Trans 21, 330. Blaise, G.A., D. Gauvin, M. Gangal and S. Authier, 2005, Nitric oxide, cell signaling and cell death, Toxicology 208, 177. Brouillette, J., M.A. Lupien, C. St-Michel and C. Fiset, 2007, Characterization of ventricular repolarization in male and female guinea pigs, J Mol Cell Cardiol 42, 357. Buja, L.M., 1998, Modulation of the myocardial response to ischemia, Lab Invest 78, 1345. Buja, L.M., 2005, Myocardial ischemia and reperfusion injury, Cardiovasc Pathol 14, 170. Buja, L.M. and M.L. Entman, 1998, Modes of myocardial cell injury and cell death in ischemic heart disease, Circulation 98, 1355. Buja, L.M., H.K. Hagler and J.T. Willerson, 1988, Altered calcium homeostasis in the pathogenesis of myocardial ischemic and hypoxic injury, Cell Calcium 9, 205. Buras, J.A., B. Holzmann and M. Sitkovsky, 2005, Animal models of sepsis: setting the stage, Nat Rev Drug Discov 4, 854. Callera, G., R. Tostes, C. Savoia, M.N. Muscara and R.M. Touyz, 2007, Vasoactive peptides in cardiovascular (patho)physiology, Expert Rev Cardiovasc Ther 5, 531. Chang, W.L., S.S. Lee and M.J. Su, 2005, Attenuation of post-ischemia reperfusion injury by thaliporphine and morphine in rat hearts, J Biomed Sci 12, 611. Chi, T.C., S.S. Lee and M.J. Su, 2006, Antihyperglycemic effect of aporphines and their derivatives in normal and diabetic rats, Planta Med 72, 1175. Chiang, E., O. Dang, K. Anderson, A. Matsuzawa, H. Ichijo and M. David, 2006, Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharide, J Immunol 176, 5720. Chiao, C.W., S.S. Lee, C.C. Wu and M.J. Su, 2005, Thaliporphine increases survival rate and attenuates multiple organ injury in LPS-induced endotoxaemia, Naunyn Schmiedebergs Arch Pharmacol 371, 34. Comstock, K.L., K.A. Krown, M.T. Page, D. Martin, P. Ho, M. Pedraza, E.N. Castro, N. Nakajima, C.C. Glembotski, P.J. Quintana and R.A. Sabbadini, 1998, LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response, J Mol Cell Cardiol 30, 2761. Copeland, S., H.S. Warren, S.F. Lowry, S.E. Calvano and D. Remick, 2005, Acute inflammatory response to endotoxin in mice and humans, Clin Diagn Lab Immunol 12, 60. Cory, S. and J.M. Adams, 2002, The Bcl2 family: regulators of the cellular life-or-death switch, Nat Rev Cancer 2, 647. Dahn, M.S., P. Lange, K. Lobdell, B. Hans, L.A. Jacobs and R.A. Mitchell, 1987, Splanchnic and total body oxygen consumption differences in septic and injured patients, Surgery 101, 69. Degousee, N., D. Angoulvant, S. Fazel, E. Stefanski, S. Saha, K. Iliescu, T.F. Lindsay, J.E. Fish, P.A. Marsden, R.K. Li, L.P. Audoly, P.J. Jakobsson and B.B. Rubin, 2006, c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytes, J Biol Chem 281, 16443. DeLeo, F.R., J. Renee, S. McCormick, M. Nakamura, M. Apicella, J.P. Weiss and W.M. Nauseef, 1998, Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly, J Clin Invest 101, 455. Fliss, H. and D. Gattinger, 1996, Apoptosis in ischemic and reperfused rat myocardium, Circ Res 79, 949. Freeman, B.D. and T.G. Buchman, 2000, Gene in a haystack: tumor necrosis factor polymorphisms and outcome in sepsis, Crit Care Med 28, 3090. Fu, Y.C., S.C. Yin, C.S. Chi, B. Hwang and S.L. Hsu, 2006, Norepinephrine induces apoptosis in neonatal rat endothelial cells via a ROS-dependent JNK activation pathway, Apoptosis 11, 2053. Fujisawa, T., K. Takeda and H. Ichijo, 2007, ASK family proteins in stress response and disease, Mol Biotechnol 37, 13. Galley, H.F. and N.R. Webster, 1996, The immuno-inflammatory cascade, Br J Anaesth 77, 11. Gautier, M., H. Zhang and I.M. Fearon, 2008, Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents, J Mol Cell Cardiol 44, 241. Green, D. and G. Kroemer, 1998, The central executioners of apoptosis: caspases or mitochondria?, Trends Cell Biol 8, 267. Guggilam, A., M. Haque, E.K. Kerut, E. McIlwain, P. Lucchesi, I. Seghal and J. Francis, 2007, TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats, Am J Physiol Heart Circ Physiol 293, H599. Ha, H.C., L.D. Hester and S.H. Snyder, 2002, Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia, Proc Natl Acad Sci U S A 99, 3270. Hamlin, R.L., A. Kijtawornrat, B.W. Keene and D.M. Hamlin, 2003, QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles, Toxicol Sci 76, 437. Hansen, J.F., 1989, Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion, Am Heart J 117, 290. Hatai, T., A. Matsuzawa, S. Inoshita, Y. Mochida, T. Kuroda, K. Sakamaki, K. Kuida, S. Yonehara, H. Ichijo and K. Takeda, 2000, Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation, J Biol Chem 275, 26576. Haunstetter, A. and S. Izumo, 1998, Apoptosis: basic mechanisms and implications for cardiovascular disease, Circ Res 82, 1111. Hiraoka, M., 1997, Pathophysiological functions of ATP-sensitive K+ channels in myocardial ischemia, Jpn Heart J 38, 297. Hotchkiss, R.S. and D.W. Nicholson, 2006, Apoptosis and caspases regulate death and inflammation in sepsis, Nat Rev Immunol 6, 813. Howell, G. and S.A. Tisherman, 2006, Management of sepsis, Surg Clin North Am 86, 1523. Hung, L., S. Lee, J. Chen, S. Huang and M. Su, 2001, Thaliporphine protects ischemic and ischemic-reperfused rat hearts via NO-dependent mechanism, Drug Development Research 52, 446. Janssens, S., K. Burns, E. Vercammen, J. Tschopp and R. Beyaert, 2003, MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression, FEBS Lett 548, 103. Javeshghani, D. and S. Magder, 2001, Presence of nitrotyrosine with minimal inducible nitric oxide synthase induction in lipopolysaccharide-treated pigs, Shock 16, 304. Kaur, K., A.K. Sharma, S. Dhingra and P.K. Singal, 2006, Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes, J Mol Cell Cardiol 41, 1023. Khadour, F.H., D. Panas, P. Ferdinandy, C. Schulze, T. Csont, M.M. Lalu, S.M. Wildhirt and R. Schulz, 2002, Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats, Am J Physiol Heart Circ Physiol 283, H1108. Komjati, K., V.C. Besson and C. Szabo, 2005, Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma, Curr Drug Targets CNS Neurol Disord 4, 179. Krown, K.A., M.T. Page, C. Nguyen, D. Zechner, V. Gutierrez, K.L. Comstock, C.C. Glembotski, P.J. Quintana and R.A. Sabbadini, 1996, Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death, J Clin Invest 98, 2854. Lee, I., E. Bender and B. Kadenbach, 2002, Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase, Mol Cell Biochem 234-235, 63. Levin, D.C., 1974, Pathways and functional significance of the coronary collateral circulation, Circulation 50, 831. Levrand, S., P. Pacher, B. Pesse, J. Rolli, F. Feihl, B. Waeber and L. Liaudet, 2007, Homocysteine induces cell death in H9C2 cardiomyocytes through the generation of peroxynitrite, Biochem Biophys Res Commun 359, 445. Levrand, S., C. Vannay-Bouchiche, B. Pesse, P. Pacher, F. Feihl, B. Waeber and L. Liaudet, 2006, Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo, Free Radic Biol Med 41, 886. Li, P., D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, E.S. Alnemri and X. Wang, 1997, Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade, Cell 91, 479. Li, S., X. Jiao, L. Tao, H. Liu, Y. Cao, B.L. Lopez, T.A. Christopher and X.L. Ma, 2007, Tumor necrosis factor-alpha in mechanic trauma plasma mediates cardiomyocyte apoptosis, Am J Physiol Heart Circ Physiol 293, H1847. Liu, P., C.E. Hock, R. Nagele and P.Y. Wong, 1997, Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats, Am J Physiol 272, H2327. Liu, S.F., R. Newton, T.W. Evans and P.J. Barnes, 1996, Differential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat, Clin Sci (Lond) 90, 301. Mariappan, N., R.N. Soorappan, M. Haque, S. Sriramula and J. Francis, 2007, TNF-alpha-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol, Am J Physiol Heart Circ Physiol 293, H2726. Marshall, J.C., 2003, Such stuff as dreams are made on: mediator-directed therapy in sepsis, Nat Rev Drug Discov 2, 391. Maxwell, M.P., D.J. Hearse and D.M. Yellon, 1987, Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction, Cardiovasc Res 21, 737. Maxwell, S.R. and G.Y. Lip, 1997, Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options, Int J Cardiol 58, 95. McDonald, T.E., M.N. Grinman, C.M. Carthy and K.R. Walley, 2000, Endotoxin infusion in rats induces apoptotic and survival pathways in hearts, Am J Physiol Heart Circ Physiol 279, H2053. Merx, M.W. and C. Weber, 2007, Sepsis and the heart, Circulation 116, 793. Moe, G.W., J. Marin-Garcia, A. Konig, M. Goldenthal, X. Lu and Q. Feng, 2004, In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure, Am J Physiol Heart Circ Physiol 287, H1813. Mullarkey, M., J.R. Rose, J. Bristol, T. Kawata, A. Kimura, S. Kobayashi, M. Przetak, J. Chow, F. Gusovsky, W.J. Christ and D.P. Rossignol, 2003, Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist, J Pharmacol Exp Ther 304, 1093. Naseem, K.M., 2005, The role of nitric oxide in cardiovascular diseases, Mol Aspects Med 26, 33. Neviere, R., H. Fauvel, C. Chopin, P. Formstecher and P. Marchetti, 2001, Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis, Am J Respir Crit Care Med 163, 218. Nguyen, H.B., E.P. Rivers, F.M. Abrahamian, G.J. Moran, E. Abraham, S. Trzeciak, D.T. Huang, T. Osborn, D. Stevens and D.A. Talan, 2006, Severe sepsis and septic shock: review of the literature and emergency department management guidelines, Ann Emerg Med 48, 28. Nicoletti, V.G. and A.M. Stella, 2003, Role of PARP under stress conditions: cell death or protection?, Neurochem Res 28, 187. Pacher, P., A. Cziraki, J.G. Mabley, L. Liaudet, L. Papp and C. Szabo, 2002, Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents, Biochem Pharmacol 64, 1785. Pacher, P. and C. Szabo, 2007, Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors, Cardiovasc Drug Rev 25, 235. Pesse, B., S. Levrand, F. Feihl, B. Waeber, B. Gavillet, P. Pacher and L. Liaudet, 2005, Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes, J Mol Cell Cardiol 38, 765. Rabkin, S.W., 2007, Nitric oxide-induced cell death in the heart: the role of autophagy, Autophagy 3, 347. Reimer, K.A. and R.E. Ideker, 1987, Myocardial ischemia and infarction: anatomic and biochemical substrates for ischemic cell death and ventricular arrhythmias, Hum Pathol 18, 462. Rudiger, A. and M. Singer, 2007, Mechanisms of sepsis-induced cardiac dysfunction, Crit Care Med 35, 1599. Ruokonen, E., J. Takala, A. Kari, H. Saxen, J. Mertsola and E.J. Hansen, 1993, Regional blood flow and oxygen transport in septic shock, Crit Care Med 21, 1296. Saraste, A., L.M. Voipio-Pulkki, M. Parvinen and K. Pulkki, 1997, Apoptosis in the heart, N Engl J Med 336, 1025. Satoh, H., 2003, Sino-atrial nodal cells of mammalian hearts: ionic currents and gene expression of pacemaker ionic channels, J Smooth Muscle Res 39, 175. Scarabelli, T.M., R. Knight, A. Stephanou, P. Townsend, C. Chen-Scarabelli, K. Lawrence, R. Gottlieb, D. Latchman and J. Narula, 2006, Clinical implications of apoptosis in ischemic myocardium, Curr Probl Cardiol 31, 181. Schmaier, A.H., 1999, Disseminated intravascular coagulation, N Engl J Med 341, 1937. Shacka, J.J., M.A. Sahawneh, J.D. Gonzalez, Y.Z. Ye, T.L. D'Alessandro and A.G. Estevez, 2006, Two distinct signaling pathways regulate peroxynitrite-induced apoptosis in PC12 cells, Cell Death Differ 13, 1506. Shimojo, T., M. Hiroe, S. Ishiyama, H. Ito, T. Nishikawa and F. Marumo, 1999, Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway, Exp Cell Res 247, 38. Shiotani, M., T. Harada, J. Abe, Y. Hamada and I. Horii, 2007, Methodological validation of an existing telemetry system for QT evaluation in conscious guinea pigs, J Pharmacol Toxicol Methods 55, 27. Song, Z.F., X.P. Ji, X.X. Li, S.J. Wang and S.H. Wang, 2007, Inhibition of the activity of Poly(ADP-Ribose) Polymerase reduces heart ischemia/reperfusion injury via suppressing JNK mediated AIF translocation, J Cell Mol Med. Su, M.J., Y.M. Chang, J.F. Chi and S.S. Lee, 1994, Thaliporphine, a positive inotropic agent with a negative chronotropic action, Eur J Pharmacol 254, 141. Sun, Y., 2007, Oxidative stress and cardiac repair/remodeling following infarction, Am J Med Sci 334, 197. Szabo, C., 2005, Cardioprotective effects of poly(ADP-ribose) polymerase inhibition, Pharmacol Res 52, 34. Szabo, G., L. Liaudet, S. Hagl and C. Szabo, 2004, Poly(ADP-ribose) polymerase activation in the reperfused myocardium, Cardiovasc Res 61, 471. Taimor, G., B. Hofstaetter and H.M. Piper, 2000, Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia, Cardiovasc Res 45, 588. Tasatargil, A., S. Dalaklioglu and G. Sadan, 2005, Inhibition of poly(ADP-ribose) polymerase prevents vascular hyporesponsiveness induced by lipopolysaccharide in isolated rat aorta, Pharmacol Res 51, 581. Taveira da Silva, A.M., H.C. Kaulbach, F.S. Chuidian, D.R. Lambert, A.F. Suffredini and R.L. Danner, 1993, Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin, N Engl J Med 328, 1457. Teng, C.M., S.M. Yu, S.S. Lee, F.N. Ko, M.J. Su and T.F. Huang, 1993, Vasoconstricting effect in rat aorta caused by thaliporphine isolated from the plant Neolitsea konishii K, Eur J Pharmacol 233, 7. Tobiume, K., A. Matsuzawa, T. Takahashi, H. Nishitoh, K. Morita, K. Takeda, O. Minowa, K. Miyazono, T. Noda and H. Ichijo, 2001, ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis, EMBO Rep 2, 222. Umansky, S.R., J.P. Shapiro, G.M. Cuenco, M.W. Foehr, I.C. Bathurst and L.D. Tomei, 1997, Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated in vitro ischemia and reperfusion, Cell Death Differ 4, 608. Wang, P. and J.L. Zweier, 1996, Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury, J Biol Chem 271, 29223. Wang, Y.P., C. Sato, K. Mizoguchi, Y. Yamashita, M. Oe and H. Maeta, 2002, Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase, Cardiovasc Res 56, 33. Wesche-Soldato, D.E., R.Z. Swan, C.S. Chung and A. Ayala, 2007, The apoptotic pathway as a therapeutic target in sepsis, Curr Drug Targets 8, 493. Wilcox, R.E., J.E. Ragan, R.S. Pearlman, M.Y. Brusniak, R.M. Eglen, D.W. Bonhaus, T.E. Tenner, Jr. and J.D. Miller, 2001, High-affinity interactions of ligands at recombinant guinea pig 5HT7 receptors, J Comput Aided Mol Des 15, 883. Wilson, M., R. Blum, P. Dandona and S. Mousa, 2001, Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: a model of human diseases, Clin Exp Pharmacol Physiol 28, 376. Yellon, D.M. and D.J. Hausenloy, 2007, Myocardial reperfusion injury, N Engl J Med 357, 1121. Zhang, M. and A.M. Shah, 2007, Role of reactive oxygen species in myocardial remodeling, Curr Heart Fail Rep 4, 26. Zhao, Z.Q. and J. Vinten-Johansen, 2002, Myocardial apoptosis and ischemic preconditioning, Cardiovasc Res 55, 438. Zingarelli, B., P.W. Hake, M. O'Connor, A. Denenberg, H.R. Wong, S. Kong and B.J. Aronow, 2004, Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1, Am J Physiol Heart Circ Physiol 286, H1408. Zuckerman, S.H. and A.M. Bendele, 1989, Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models, Infect Immun 57, 3009. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37791 | - |
dc.description.abstract | Thaliporphine是由樟科植物分離出來的阿朴酚類生物鹼,對5HT7接受器有很高的親和力。在之前的研究得知,thaliporphine在心臟缺血再灌流具有保護作用,也具有降血糖作用,而且在敗血症動物可以減少多重器官衰竭發生,增加存活率。
敗血症是一個複雜性的發炎疾病。大量的細胞激素及發炎物質產生,像是TNFα、自由基及一氧化氮,會導致pro- 和 anti- 細胞凋零路徑不平衡。敗血症也會導致凝血功能異常,容易產生瀰漫性血管性凝血,減少血液灌流及器官氧氣供給,導致多重器官衰竭。目前對於敗血症充斥的發炎物質,是否影響心臟缺血再灌流時細胞存活,並不是很清楚。本篇研究當內毒素血症動物續發心臟缺血再灌流,影響細胞存活及死亡的訊息傳遞,並且探討thaliporphine是否具有心臟保護的作用。 本篇以LPS 1mg/kg腹腔注射誘導天竺鼠內毒素血症,並且有些動物在誘導的同時給予thaliporphine。給藥24小時候,天竺鼠以pentobarbital 40mg/kg腹腔注射麻醉,開胸後,心臟左主冠狀動脈結紮,模擬缺血三十分鐘,再放鬆灌流一小時後,取出心臟,以TTC染色看壞死面積,或是萃取心臟蛋白質。和控制組比較,內毒素血症動物續發心臟缺血再灌流會明顯增加壞死面積,並且延長心臟QTc數值,同時給予thaliporphine可以減少心臟壞死面積,但是此保護作用,不受pimozide (1mg/kg, i.p.) 5HT7接受器抑制劑影響。 心臟蛋白質分為正常及缺血區域,觀察其蛋白質表現變化。內毒素血症正常區域中,蛋白質Bax、被切斷PARP以及JNK磷酸化會明顯增加,缺血區域中,這些蛋白質會更顯著增加,並且caspase 9活性明顯增加。 Thaliporphine可以明顯減少正常及缺血區域中JNK磷酸化及PARP被切斷。缺血區域中所增加的Bax表現及caspase 9活性增加-,也都能被thaliporphine所抑制。 心臟細胞內的自由基及一氧化氮分別以CM-H2DCFDA和DAF-AM測得。在天竺鼠內毒素血症中,自由基及一氧化氮明顯增加,同時給予thaliporphine可以減少此現象。心臟中cGMP含量也跟著增加,但是此現象卻無法被thaliporphine明顯改善。 總之,在天竺鼠內毒素血症會活化pro-細胞凋零途徑,所以會導致心臟續發缺血再灌流時壞死面積增加。自由基及一氧化氮會產生大量的peroxynitrite,增加細胞凋零途徑活化。Thaliporphine可以減少心臟細胞中自由基及一氧化氮含量,減少了JNK磷酸化,所以可以減少細胞凋零路徑活化,使得內毒素血症續發心臟缺血再灌流時,壞死面積減少。Thaliporphine的心臟保護作用,並非經由5HT7接受器和抑制cGMP路徑而來。Thaliporphine是經由哪個分子層面,減少內毒素血症細胞凋零路徑活化,仍需進一步探討。 | zh_TW |
dc.description.abstract | Thaliporphine is a phenolic aporphine alkaloid which is isolated from Lauraceae, and has high affinity to 5HT7 receptor. Our previous study found that thaliporphine exerted cardioprotection in ischemia-reperfused rat hearts, anti-hyperglycemic effect, and anti-septic effect with the benefit of increasing survival rate and attenuating multiple organ failure.
Sepsis is a complicated inflammatory disease. Under pathophysiological conditions, the elevated plasma level of cytokines and inflammatory mediators, such as TNFα, reactive oxygen species, and NO, may cause imbalance between pro- and anti- apoptotic signalings in multiple organs. The imbalance of coagulation and anticoagulation system may increase the occurrence of disseminated intravascular coagulation, and decrease organ blood perfusion and oxygen supply, which result in multiple organ failure. It remains unclear whether cell death could be enhanced in ischemia-reperfused hearts under the circumstance of endotoxemia. The present study aimed to investigate the underlying signaling of cell survival or death in endotoxemic guinea pig hearts subjected to ischemia reperfusion injury, and to examine whether thaliporphine could have benefit in the cardioprotection against ischemia reperfusion injury. Endotoxemic guinea pigs were induced by intraparenteral injection of lipopolysaccaride (LPS) 1mg/kg with or without thaliporphine coadministration. After LPS injection for 24 hours, guinea pigs were anethetized by pentobarbital (40mg/kg, i.p.) to perform the thoracotomy, and the left anterior decending coronary artery of guinea pig hearts were ligated for 30 mins and followed by reperfusion for 1h before excising the heart for the measurement of infarct size by TTC stain or for the protein extraction. As compared with the sham group, the infarct size was markedly increased in association with a prolongation of QTc interval in endotoxemic heart subjected to ischemia reperfusion injury, which could be significantly attenuated in thaliporphine coadministrated endotoxemic guinea pigs. Thaliporphine mediated cardioprotective effect was not affected by pimozide (1mg/kg, i.p.) 5HT7 receptor inhibition. The alteration of protein expression was separatedly analyzed in the non-risk and the risk area of endotoxemic guinea pig hearts subjected to ischemic reperfusion injury. In the non risk area of endotoxemic heart, the protein level of Bax, cleaved PARP, and phospho-JNK was significantly elevated without altering the caspase 9 activity, which was further enhanced in risk area of myocardium in association with the pronounced increase of caspase 9 activity. Thaliporphine treatment significantly attenuated the increased level of phospho-JNK and the cleaved PARP in both non-risk area and risk area of ischemia reperfusion hearts. The suppression of Bax expression by thaliporphine in risk area was in parallel with the attenuation of caspase 9 activity. The intracellular level of ROS and nitric oxide was measured by loading the isolated ventricular cells of guinea pig with CM-H2DCFDA and DAF-AM, respectively. In endotoxemic guinea-pig hearts, the intracellular concentration of both ROS and NO were markedly increased, which was significantly attenuated in thaliporphine coadministrated group. The increased cGMP level was found in endotoxemic guinea pig hearts and was not significantly altered in thaliporphine coadminstrated endotoxemic guinea pig hearts. In conclusion, the pro-apoptotic signaling was initiated in endotoxemic guinea pig hearts, which had an impact on the tolerance of myocardium against ischemia reperfusion injury. The elevated oxidative stress in endotoxemic guinea pig hearts may increase the formation of oxidative mediators, such as peroxynitrite, to enhance the apoptotic pathway, which results in the aggravation of myocardial infarction after ischemia reperfusion. Thaliporphine treatment attenuated the intracellular ROS and NO in association with the inhibition of JNK phosphorylation which contributed to the anti-apoptotic action and the amelioration of myocardial infarction. Thaliporphine mediated cardioprotective effect was not mediated through the activation of 5HT7 receptor or inhibition cGMP- dependent pathway. The molecular targets of thaliporphine mediated anti-apoptosis in endotoxemic guinea pig hearts remains for further investigation. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T15:44:00Z (GMT). No. of bitstreams: 1 ntu-97-R95443013-1.pdf: 1707735 bytes, checksum: 5d84ce2fbaf9b8001bd9711517f65897 (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 目錄 ii
縮寫對照表(Abbreviation) iii 中文摘要 vi Abstract viii 第一章 緒論 2 第二章 實驗步驟與方法 13 第三章 實驗結果 22 第四章 討論 42 第五章 總結與展望 49 參考文獻 51 | |
dc.language.iso | zh-TW | |
dc.title | Thaliporphine保護天竺鼠內毒素血症對抗心臟缺血再灌流損傷之機轉 | zh_TW |
dc.title | Mechanisms of cardioprotective effect of thaliporphine against ischemia reperfusion injury in endotoxemic guinea pigs | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 賴凌平(Ling-Ping Lai),林正一(Cheng-I Lin),吳錦楨(Chin-Chen Wu) | |
dc.subject.keyword | 阿朴酚類生物鹼 內毒素 缺血再灌流 細胞死亡, | zh_TW |
dc.subject.keyword | thaliporphine lps ischemia reperfusion cell death, | en |
dc.relation.page | 56 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-07-03 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 1.67 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。